These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25582770)

  • 1. Has psychiatry tamed the "ketamine tiger?" Considerations on its use for depression and anxiety.
    Rasmussen KG
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():218-24. PubMed ID: 25582770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ketamine for treatment of acute depression].
    Hjerrild S; Bjerre J; Pedersen RH; Videbech P
    Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine: repurposing and redefining a multifaceted drug.
    Potter DE; Choudhury M
    Drug Discov Today; 2014 Dec; 19(12):1848-54. PubMed ID: 25224017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine and magnesium common pathway of antidepressant action.
    Górska N; Cubała WJ; Słupski J; Gałuszko-Węgielnik M
    Magnes Res; 2018 May; 31(2):33-38. PubMed ID: 30398153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
    Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.
    Glue P; Medlicott NJ; Harland S; Neehoff S; Anderson-Fahey B; Le Nedelec M; Gray A; McNaughton N
    J Psychopharmacol; 2017 Oct; 31(10):1302-1305. PubMed ID: 28441895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous ketamine for treatment-resistant major depressive disorder.
    Covvey JR; Crawford AN; Lowe DK
    Ann Pharmacother; 2012 Jan; 46(1):117-23. PubMed ID: 22190250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ketamine's antidepressant effect: focus on ketamine mechanisms of action].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):48-55. PubMed ID: 24434007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.
    Sos P; Klirova M; Novak T; Kohutova B; Horacek J; Palenicek T
    Neuro Endocrinol Lett; 2013; 34(4):287-93. PubMed ID: 23803871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression].
    Gosek P; Chojnacka M; Bieńkowski P; Swiecicki Ł
    Psychiatr Pol; 2012; 46(2):283-94. PubMed ID: 23214398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review.
    Molero P; Ramos-Quiroga JA; Martin-Santos R; Calvo-Sánchez E; Gutiérrez-Rojas L; Meana JJ
    CNS Drugs; 2018 May; 32(5):411-420. PubMed ID: 29736744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.
    Zhang MW; Harris KM; Ho RC
    BMC Med Ethics; 2016 Jan; 17():4. PubMed ID: 26768892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant actions of ketamine: from molecular mechanisms to clinical practice.
    Monteggia LM; Zarate C
    Curr Opin Neurobiol; 2015 Feb; 30():139-43. PubMed ID: 25562451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How much alcohol is in ketamine's antidepressant action?
    Bonnet U
    Life Sci; 2017 Jan; 168():54-57. PubMed ID: 27836553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H; Iijima M; Chaki S
    Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.
    Katalinic N; Lai R; Somogyi A; Mitchell PB; Glue P; Loo CK
    Aust N Z J Psychiatry; 2013 Aug; 47(8):710-27. PubMed ID: 23661785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
    Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
    Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond Ketamine: New Approaches to the Development of Safer Antidepressants.
    Chaki S
    Curr Neuropharmacol; 2017; 15(7):963-976. PubMed ID: 28228087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA antagonists under investigation for the treatment of major depressive disorder.
    Pochwat B; Pałucha-Poniewiera A; Szewczyk B; Pilc A; Nowak G
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1181-92. PubMed ID: 24818801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid antidepressant effects of ketamine ignite drug discovery.
    Dolgin E
    Nat Med; 2013 Jan; 19(1):8. PubMed ID: 23295995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.